geneCORE Immunotherapy panel-1 that contains TMB (Tumor Mutational Burden), PD-L1 (22C3 Dako) expression, and MSI (Microsatellite instability) testing, is a comprehensive molecular diagnostic panel. It uses next-generation sequencing (NGS) technology to analyz...
geneCORE Immunotherapy panel-1 that contains TMB (Tumor Mutational Burden), PD-L1 (22C3 Dako) expression, and MSI (Microsatellite instability) testing, is a comprehensive molecular diagnostic panel. It uses next-generation sequencing (NGS) technology...
geneCORE Immunotherapy panel-1 that contains TMB (Tumor Mutational Burden), PD-L1 (22C3 Dako) expression, and MSI (Microsatellite instability) testing, is a comprehensive molecular diagnostic panel. It uses next-generation sequencing (NGS) technology to analyze 161 genes associated with various cancers. The panel assesses genetic alterations, TMB levels, PD-L1 (22C3 Dako) expression, and MSI status simultaneously. This integrated approach provides valuable information about the tumor's genetic profile, immune micro...
geneCORE Immunotherapy Panel-1 includes PDL-1 22C3 Dako, TMB, MSI.
Showing 3 of 3 tests
The PDL-1 22C3 Dako test is an advanced diagnostic test used to measure the expression of the PD-L1 protein on tumor cells. It helps determine whether a patient may respond well to immunotherapy drugs such as pembrolizumab (Keytruda).
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.